Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Multiple Sclerosis

In brief

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS)

Key facts

Study ID
NCT01892722
Run by
Novartis Pharmaceuticals
People needed
240
Starts
2013-07-26
Expected to finish
2030-02-18
Last updated by the study team
2026-06-08

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.